Anu Airaksinen
Turku PET Centre anu.airaksinen@utu.fi +358 29 450 2199 +358 50 470 7622 ORCID identifier: https://orcid.org/0000-0002-5943-3105 |
Areas of expertise
radiopharmaceutical chemistry; PET radiochemistry; image guided drug delivery; pretargeted PET imaging; theranostics; nanotheranostics
radiopharmaceutical chemistry; PET radiochemistry; image guided drug delivery; pretargeted PET imaging; theranostics; nanotheranostics
Publications
- Synthesis and ex vivo biodistribution of two 68Ga-labeled tetrazine tracers: Comparison of pharmacokinetics (2022)
- Nuclear Medicine and Biology
(A1 Refereed original research article in a scientific journal) - A Theranostic Cellulose Nanocrystal-Based Drug Delivery System with Enhanced Retention in Pulmonary Metastasis of Melanoma (2021)
- Small
(A1 Refereed original research article in a scientific journal) - Biological evaluation of [18F]FDG-Tz as a tracer candidate for pretargeted PET imaging (2021)
- Nuclear Medicine and Biology
(Other publication) - Exploring the Biochemical Foundations of a Successful GLUT1-Targeting Strategy to BNCT: Chemical Synthesis and In Vitro Evaluation of the Entire Positional Isomer Library of ortho-Carboranylmethyl-Bearing Glucoconjugates (2021)
- Molecular Pharmaceutics
(A1 Refereed original research article in a scientific journal) - First-in-Human Study of 68 Ga-DOTA-Siglec-9, PET Ligand Targeting Vascular Adhesion Protein 1 (2021)
- Journal of Nuclear Medicine
(A1 Refereed original research article in a scientific journal) - Investigation of silicon nanoparticles produced by centrifuge chemical vapor deposition for applications in therapy and diagnostics (2021)
- European Journal of Pharmaceutics and Biopharmaceutics
(A1 Refereed original research article in a scientific journal) - Radiolabeling of Theranostic Nanosystems (2021) Bio-Nanomedicine for Cancer Therapy Das Sudeep, Imlimthan Surachet, Airaksinen Anu J., Sarparanta Mirkka
(A3 Refereed book chapter or chapter in a compilation book) - Addressing the Biochemical Foundations of a Glucose-Based "Trojan Horse"-Strategy to Boron Neutron Capture Therapy: From Chemical Synthesis to In Vitro Assessment (2020)
- Molecular Pharmaceutics
(A1 Refereed original research article in a scientific journal) - Comparison of Clinically Relevant Oncolytic Virus Platforms for Enhancing T Cell Therapy of Solid Tumors (2020)
- Molecular Therapy - Oncolytics
(A1 Refereed original research article in a scientific journal) - Engineered antibody-functionalized porous silicon nanoparticles for therapeutic targeting of pro-survival pathway in endogenous neuroblasts after stroke (2020)
- Biomaterials
(A1 Refereed original research article in a scientific journal)



